Oxabolone
Oxabolone
Oxabolone is a synthetic anabolic-androgenic steroid (AAS) derived from nandrolone. It is known for its potential use in hormone replacement therapy and its effects on muscle growth and development. Oxabolone is chemically similar to other nandrolone derivatives but has unique properties that distinguish it from other AAS.
Chemical Properties
Oxabolone is characterized by its chemical structure, which includes a modification of the nandrolone molecule. This modification enhances its anabolic properties while reducing its androgenic effects. The chemical formula of Oxabolone is C20H28O3, and it is often administered in the form of its ester, oxabolone cipionate, to prolong its activity in the body.
Mechanism of Action
Oxabolone works by binding to androgen receptors in the body, which leads to an increase in protein synthesis and muscle growth. It also influences the production of red blood cells and can enhance nitrogen retention in muscles, contributing to its anabolic effects. Unlike some other AAS, Oxabolone has a lower affinity for conversion to dihydrotestosterone (DHT), which reduces the risk of androgenic side effects.
Medical Uses
Oxabolone has been studied for its potential use in treating conditions such as muscle wasting and osteoporosis. It may also be used in certain cases of hypogonadism where testosterone replacement is necessary. However, its use is limited due to the availability of other more established treatments.
Side Effects
As with other anabolic steroids, Oxabolone can cause a range of side effects. These may include liver toxicity, changes in cholesterol levels, and potential cardiovascular issues. It may also cause virilization in women and gynecomastia in men due to its estrogenic activity.
Legal Status
The legal status of Oxabolone varies by country. In many places, it is classified as a controlled substance due to its potential for abuse and side effects. It is important for users to be aware of the legal implications of using Oxabolone without a prescription.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD